eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2005, Volume 1, Issue 1 : 34-40 doi: ijmmas.2005.34.40
Research Article
"Inhibition of Some Human Pathogens with Tropical Plants Extracts Chromolaena odorata and Citrus aurantifolia and Some Antibiotics"
Published
Sept. 30, 2005
Abstract

"Four pathogens (Bacillus cereus, Staphylococcus aureus, Escherichia coli and Salmonella typhi) were used for the study of antimicrobial effects of Chromolaena odorata and Citrus aurantifolia leaf extracts. Solvents used for the extraction of the active ingredients of the plant leaves were water and ethanol. The antibiotics evaluated included erythromycin, tetracycline and penicillin. The antimicrobial effects of the plant extracts showed both extracts were inhibitory to the four pathogens. The minimum inhibitory concentration (MIC) of the extracts on the organisms ranged between 0.01563-0.0625mg mLG for Bacillus cereus, 0.0156-10.25 mg mLG for Staphylococcus aureus, 0.125-0.5 mg mLG for Escherichia coli and 0.25-0.5 mg mLG for 1 1 1 Salmonella typhi. The effects varied with solvent type of extract, concentrations of the leaf extract and the organisms. Erythromycin was inhibitory to Bacillus cereus, Staphylococcus aureus and Salmonella typhi, tetracycline was inhibitory to Bacillus cereus and Staphylococcus aureus while penicillin was inhibitory only to Staphylococcus aureus. The three antibiotics had no cidal or static effect on Escherichia coli. The antimicrobial effect of leaf extracts of Chromolaena odorata and Citrus aurantifolia is discussed in relation
to the development of drugs or antimicrobial agents in Nigeria."

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Smart Hospitals and Healthcare Automation: Transforming Healthcare Delivery Through Artificial Intelligence, Internet of Medical Things, and Intelligent Automation
16-20
Impact of Dual Antiplatelet Therapy Duration on Post-PCI Outcomes
11-14
PCI Outcomes in Patients With Chronic Total Occlusion
14-17
PCI Safety in Elderly Patients Above 75 Years
26-30
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.